BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29559743)

  • 21. Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of residual hepatocellular carcinoma through the HIF-1α/BNIP3 signaling pathway.
    Xu WL; Wang SH; Sun WB; Gao J; Ding XM; Kong J; Xu L; Ke S
    BMB Rep; 2019 Apr; 52(4):277-282. PubMed ID: 30940322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition mediated by interleukin-6/signal transducer and activator of transcription 3/Snail pathway in the H22 cells.
    Zhou T; Liu B; Wang Y; Wang W; Chang H; Li D; Li Y; Song Z
    J Cancer Res Ther; 2020 Sep; 16(5):1112-1118. PubMed ID: 33004756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner.
    Tan L; Chen S; Wei G; Li Y; Liao J; Jin H; Zou Y; Huang M; Peng Z; Guo Y; Peng S; Xu L; Kuang M
    Cancer Lett; 2019 Sep; 460():29-40. PubMed ID: 31173855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
    Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
    Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy.
    Shi L; Wang J; Ding N; Zhang Y; Zhu Y; Dong S; Wang X; Peng C; Zhou C; Zhou L; Li X; Shi H; Wu W; Long X; Wu C; Liao W
    Nat Commun; 2019 Nov; 10(1):5421. PubMed ID: 31780645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma.
    Xu LX; He MH; Dai ZH; Yu J; Wang JG; Li XC; Jiang BB; Ke ZF; Su TH; Peng ZW; Guo Y; Chen ZB; Chen SL; Peng S; Kuang M
    Ann Oncol; 2019 Jun; 30(6):990-997. PubMed ID: 30916311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular Carcinoma: Etiology and Current and Future Drugs.
    Jindal A; Thadi A; Shailubhai K
    J Clin Exp Hepatol; 2019; 9(2):221-232. PubMed ID: 31024205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy.
    Guo Y; Wu Z; Shen S; Guo R; Wang J; Wang W; Zhao K; Kuang M; Shuai X
    Nat Commun; 2018 Aug; 9(1):3430. PubMed ID: 30143633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STIP1 is over-expressed in hepatocellular carcinoma and promotes the growth and migration of cancer cells.
    Luo X; Liu Y; Ma S; Liu L; Xie R; Li M; Shen P; Wang S
    Gene; 2018 Jul; 662():110-117. PubMed ID: 29596884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment.
    Zhang R; Ma M; Lin XH; Liu HH; Chen J; Chen J; Gao DM; Cui JF; Ren ZG; Chen RX
    BMC Cancer; 2018 Sep; 18(1):901. PubMed ID: 30227844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway.
    Yin H; Deng Z; Li X; Li Y; Yin W; Zhao G; Jiang D; Sun C; Zhou Y
    Cancer Genet; 2019 Sep; 237():1-9. PubMed ID: 31447061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
    Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
    Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insufficient radiofrequency ablation promotes hepatocellular carcinoma cell progression via autophagy and the CD133 feedback loop.
    Wang X; Deng Q; Feng K; Chen S; Jiang J; Xia F; Ma K; Bie P
    Oncol Rep; 2018 Jul; 40(1):241-251. PubMed ID: 29749472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome-transferred long non-coding RNA ASMTL-AS1 contributes to malignant phenotypes in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
    Ma D; Gao X; Liu Z; Lu X; Ju H; Zhang N
    Cell Prolif; 2020 Sep; 53(9):e12795. PubMed ID: 32722884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy.
    Minami Y; Nishida N; Kudo M
    Eur Radiol; 2019 Sep; 29(9):5045-5051. PubMed ID: 30963271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ICAM-1 Activates Platelets and Promotes Endothelial Permeability through VE-Cadherin after Insufficient Radiofrequency Ablation.
    Kong J; Yao C; Dong S; Wu S; Xu Y; Li K; Ji L; Shen Q; Zhang Q; Zhan R; Cui H; Zhou C; Niu H; Li G; Sun W; Zheng L
    Adv Sci (Weinh); 2021 Feb; 8(4):2002228. PubMed ID: 33643788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.
    Liao J; Jin H; Li S; Xu L; Peng Z; Wei G; Long J; Guo Y; Kuang M; Zhou Q; Peng S
    J Exp Clin Cancer Res; 2019 Nov; 38(1):454. PubMed ID: 31694662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas.
    Huang M; He M; Guo Y; Li H; Shen S; Xie Y; Li X; Xiao H; Fang L; Li D; Peng B; Liang L; Yu J; Kuang M; Xu L; Peng S
    Clin Cancer Res; 2020 Sep; 26(18):4947-4957. PubMed ID: 32527942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irreversible electroporation induces CD8
    Dai Z; Wang Z; Lei K; Liao J; Peng Z; Lin M; Liang P; Yu J; Peng S; Chen S; Kuang M
    Cancer Lett; 2021 Apr; 503():1-10. PubMed ID: 33444692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet lysates in Hepatocellular Carcinoma patients after radiofrequency ablation facilitate tumor proliferation, invasion and vasculogenic mimicry.
    Jia G; Kong J; Yao C; Wu S; Sun W
    Int J Med Sci; 2020; 17(14):2104-2112. PubMed ID: 32922171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.